KY 234 is an orally effective inhibitor that targets thromboxane A2 production, with an IC50 of 5 µM. KY 234 significantly inhibits leukotriene D4 (LTD4), histamine, and antigen-induced bronchoconstriction in guinea pigs, with IC50 values of 6.0 mg/kg, 2.5 mg/kg, and 6.3 mg/kg, respectively[1].
Molecular Weight:
555.65
CAS Number:
[172544-75-1]
Formula:
C33H34N5NaO2
Target:
Histamine Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted